These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20286899)

  • 1. Effect of different adsorbents on the toxicity of cobra-venom.
    SARKAR NK; MAITRA SR
    Ann Biochem Exp Med; 1946; 6(2):89. PubMed ID: 20286899
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ultra-violet rays on the stability of cobra-venom and cardiotoxin.
    SARKAR NK; MAITRA SR
    Ann Biochem Exp Med; 1946; 6(2):87. PubMed ID: 20286898
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of cobra venom and cardiotoxin on gastroenemius-sciatic preparation of a frog.
    SARKAR NK; MAITRE SR
    Am J Physiol; 1950 Oct; 163(1):209-11. PubMed ID: 14771295
    [No Abstract]   [Full Text] [Related]  

  • 4. Action mechanism of cobra venom, cardiotoxin and allied substances on muscle contraction.
    SARKAR NK
    Proc Soc Exp Biol Med; 1951 Nov; 78(2):469-71. PubMed ID: 14911918
    [No Abstract]   [Full Text] [Related]  

  • 5. Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins.
    Laustsen AH; Gutiérrez JM; Lohse B; Rasmussen AR; Fernández J; Milbo C; Lomonte B
    Toxicon; 2015 Jun; 99():23-35. PubMed ID: 25771242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological properties of cardiotoxins isolated from cobra venom.
    Hider RC; Khader F
    Toxicon; 1982; 20(1):175-9. PubMed ID: 7080031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of substrate inhibition of synaptosomal acetylcholinesterase by cardiotoxins.
    Ranaei-Siadat SO; Riazi GH; Sadeghi M; Chang LS; Lin SR; Eghtesadi-Araghi P; Hakimelahi GH; Moosavi-Movahedi AA
    J Biochem Mol Biol; 2004 May; 37(3):330-8. PubMed ID: 15469715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of cardiotoxin-like basic polypeptide from cobra venom.
    Dubovskii PV; Ignatova AA; Feofanov AV; Utkin YN; Efremov RG
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126890. PubMed ID: 31870648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological cross-reactivity and neutralization of the principal toxins of Naja sumatrana and related cobra venoms by a Thai polyvalent antivenom (Neuro Polyvalent Snake Antivenom).
    Leong PK; Fung SY; Tan CH; Sim SM; Tan NH
    Acta Trop; 2015 Sep; 149():86-93. PubMed ID: 26026717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conformation of cardiotoxins and neurotoxins from snake venoms.
    Visser L; Louw AI
    Biochim Biophys Acta; 1978 Mar; 533(1):80-9. PubMed ID: 638198
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible orientation change of cardiotoxin molecule during its interaction with phospholipid monolayer.
    Bougis P; Rochat H; Piéroni G; Verger R
    Toxicon; 1982; 20(1):187-90. PubMed ID: 7080032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural factors affect the interactions of anticardiotoxin antibodies and cobra venom cardiotoxins.
    Chang LS; Lo YR; Lin SR
    Biochem Mol Biol Int; 1998 Mar; 44(3):529-34. PubMed ID: 9556214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing stabilities of snake venom cardiotoxins in acidic aqueous acetonitrile.
    Osthoff G
    Int J Biochem; 1990; 22(1):7-9. PubMed ID: 2328821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are interactions with phospholipids responsible for pharmacological activities of cardiotoxins?
    Bougis P; Tessier M; Van Rietschoten J; Rochat H; Faucon JF; Dufourcq J
    Mol Cell Biochem; 1983; 55(1):49-64. PubMed ID: 6353198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation by immunoaffinity chromatography of phospholipase-free cardiotoxins from the venom of the Elapidae snake Naja mossambica mossambica.
    Delori P; Tessier M
    Biochimie; 1980; 62(4):287-8. PubMed ID: 17941186
    [No Abstract]   [Full Text] [Related]  

  • 16. Delineating residues for haemolytic activities of snake venom cardiotoxin 1 from Naja naja as probed by molecular dynamics simulations and in vitro validations.
    Gorai B; Sivaraman T
    Int J Biol Macromol; 2017 Feb; 95():1022-1036. PubMed ID: 27984143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cobra venom cardiotoxins as probes of altered membrane structure in dystrophic skeletal muscle.
    Parker CJ; Hudson RA
    Biochem Biophys Res Commun; 1981 May; 100(2):746-52. PubMed ID: 6268074
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of the toxic site of Naja mossambica cardiotoxins: small synthetic peptides express an in vivo lethality.
    Marchot P; Bougis PE; Ceard B; Van Rietschoten J; Rochat H
    Biochem Biophys Res Commun; 1988 Jun; 153(2):642-7. PubMed ID: 3382394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of snake venom cardiotoxins to heart cell membranes.
    Tönsing L; Potgieter DJ; Louw AI; Visser L
    Biochim Biophys Acta; 1983 Jul; 732(1):282-8. PubMed ID: 6871194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of phospholipid monolayers by cardiotoxins.
    Bougis P; Rochat H; Piéroni G; Verger R
    Biochemistry; 1981 Aug; 20(17):4915-20. PubMed ID: 7295658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.